Achaogen, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 36 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-09-25: Reporting owner Friedland Ian; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-09-25: Reporting owner Friedland Ian; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-03-27: Reporting owner BOERNER CHRISTOPHER S.; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2014-03-11: Reporting owner ROBERTS BRYAN E; Form 4; Security Stock Option (right to buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-09-25 | Friedland Ian Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +97,500 97,500 owned after | $8.04 exercise price | 2014-10-27 | |
| 2014-09-25 | Friedland Ian Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +52,500 52,500 owned after | $8.04 exercise price | 2014-10-27 | |
| 2014-03-27 | BOERNER CHRISTOPHER S. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +20,000 20,000 owned after | $18.03 exercise price | 2014-03-31 | |
| 2014-03-11 | ROBERTS BRYAN E Director, 10% Owner | 4 | Stock Option (right to buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | ROCKLAGE SCOTT M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | Smither John W Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | DOYLE JOHN C Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | BERTOCCI DEREK A Officer (SVP and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +81,250 81,250 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | BERTOCCI DEREK A Officer (SVP and CFO) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +43,750 43,750 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | WALSH CHRISTOPHER T PHD Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 | Samuels Camille D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +10,000 10,000 owned after | $12.00 exercise price | 2014-03-13 | |
| 2014-03-11 holding as of filing | Smither John W Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.24 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | DOYLE JOHN C Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.62 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | DOYLE JOHN C Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.93 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | DOYLE JOHN C Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | DOYLE JOHN C Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.73 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | WALSH CHRISTOPHER T PHD Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.07 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | WALSH CHRISTOPHER T PHD Director | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.73 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.93 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.93 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.93 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.24 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hillan Kenneth Director, Officer (President and CEO) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.24 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hom Dennis Officer (VP, Finance and Corp. Dev.) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.73 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Hom Dennis Officer (VP, Finance and Corp. Dev.) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.73 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Murray Christine Officer (VP, Regulatory Affairs) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Murray Christine Officer (VP, Regulatory Affairs) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $4.73 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Murray Christine Officer (VP, Regulatory Affairs) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.24 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Filice Becki Officer (SVP, Development Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $6.93 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Filice Becki Officer (SVP, Development Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Filice Becki Officer (SVP, Development Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Filice Becki Officer (SVP, Development Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $7.26 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Filice Becki Officer (SVP, Development Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.24 exercise price | 2014-03-11 | ||
| 2014-03-11 holding as of filing | Filice Becki Officer (SVP, Development Operations) | 3 | Stock Option (Right to Buy) Derivative · Direct | Holding | $9.24 exercise price | 2014-03-11 |